RESUMO
REASONS FOR PERFORMING STUDY: Hyperinsulinaemia is implicated in the pathogenesis of endocrinopathic laminitis. Insulin can bind to different receptors: two insulin receptor isoforms (InsR-A and InsR-B), insulin-like growth factor-1 receptor (IGF-1R) and InsR/IGF-1R hybrid receptor (Hybrid). Currently, mRNA expression of these receptors in equine tissues and the influence of body type and dietary carbohydrate intake on expression of these receptors is not known. OBJECTIVES: The study objectives were to characterise InsR-A, InsR-B, IGF-1R and Hybrid expression in lamellar tissue (LT) and insulin responsive tissues from horses and examine the effect of dietary nonstructural carbohydrate (NSC) on mRNA expression of these receptors in LT, skeletal muscle, liver and two adipose tissue (AT) depots of lean and obese ponies. STUDY DESIGN: In vivo experiment. METHODS: Lamellar tissue samples were evaluated by quantitative reverse transcription polymerase chain reaction (RT-qPCR) for receptor mRNA expression (n = 8) and immunoblotting for protein expression (n = 3). Archived LT, skeletal muscle, liver and AT from lean and obese mixed-breed ponies fed either a low (~7% NSC as dry matter; 5 lean, 5 obese) or high NSC diet (~42% NSC as dry matter; 6 lean, 6 obese) for 7 days were evaluated by RT-qPCR to determine the effect of body condition and diet on expression of the receptors in different tissues. Significance was set at P≤0.05. RESULTS: Lamellar tissue expresses both InsR isoforms, IGF-1R and Hybrid. LT IGF-1R gene expression was greater than either InsR isoform and InsR-A expression was greater than InsR-B (P≤0.05). Obesity significantly lowered IGF-1R, InsR-A and InsR-B mRNA expression in LT and InsR-A in tailhead AT. High NSC diet lowered expression of all three receptor types in liver; IGF-1R and InsR-A in LT and InsR-A in tailhead AT. CONCLUSIONS: Lamellar tissue expresses IGF-1R, InsR isoforms and Hybrids. The functional characteristics of these receptors and their role in endocrinopathic laminitis warrants further investigation.
Assuntos
Doenças dos Cavalos/metabolismo , Insulina/metabolismo , Obesidade/veterinária , Receptor IGF Tipo 1/metabolismo , Receptor de Insulina/metabolismo , Ração Animal/análise , Fenômenos Fisiológicos da Nutrição Animal , Animais , Dieta/veterinária , Carboidratos da Dieta/efeitos adversos , Doenças do Pé/veterinária , Regulação da Expressão Gênica/fisiologia , Cavalos , Obesidade/induzido quimicamente , Obesidade/metabolismo , Isoformas de Proteínas , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Receptor de Insulina/genéticaRESUMO
Acrylamide is an animal carcinogen and probable human carcinogen present in appreciable amounts in heated carbohydrate-rich foodstuffs. It is also a germ cell mutagen, inducing dominant lethal mutations and heritable chromosomal translocations in postmeiotic sperm of treated mice. Acrylamide's affinity for male germ cells has sometimes been overlooked in assessing its toxicity and defining human health risks. Previous investigations of acrylamide's germ cell activity in mice showed stronger effects after repeated administration of low doses compared with a single high dose, suggesting the possible involvement of a stable metabolite. A key oxidative metabolite of acrylamide is the epoxide glycidamide, generated by cytochrome P4502E1 (CYP2E1). To explore the role of CYP2E1 metabolism in the germ cell mutagenicity of acrylamide, CYP2E1-null and wild-type male mice were treated by intraperitoneal injection with 0, 12.5, 25, or 50 mg acrylamide (5 ml saline)(-1) kg(-1) day(-1) for 5 consecutive days. At defined times after exposure, males were mated to untreated B6C3F1 females. Females were killed in late gestation and uterine contents were examined. Dose-related increases in resorption moles (chromosomally aberrant embryos) and decreases in the numbers of pregnant females and the proportion of living fetuses were seen in females mated to acrylamide-treated wild-type mice. No changes in any fertility parameters were seen in females mated to acrylamide-treated CYP2E1-null mice. Our results constitute the first unequivocal demonstration that acrylamide-induced germ cell mutations in male mice require CYP2E1-mediated epoxidation of acrylamide. Thus, CYP2E1 polymorphisms in human populations, resulting in variable enzyme metabolic activities, may produce differential susceptibilities to acrylamide toxicities.
Assuntos
Acrilamidas/toxicidade , Citocromo P-450 CYP2E1/genética , Mutagênicos/toxicidade , Mutação , Espermatozoides/fisiologia , Animais , Animais Endogâmicos , Citocromo P-450 CYP2E1/efeitos dos fármacos , Implantação do Embrião , Feminino , Desenvolvimento Fetal/efeitos dos fármacos , Desenvolvimento Fetal/genética , Genes Letais , Masculino , Camundongos , Camundongos Mutantes , Testes de Mutagenicidade , Gravidez , Taxa de Gravidez , Espermatozoides/efeitos dos fármacosRESUMO
Many human immunodeficiency virus (HIV)-infected persons receive prolonged treatment with DNA-reactive antiretroviral drugs. A prospective study was conducted of 26 HIV-infected men who provided samples before treatment and at multiple times after beginning treatment, to investigate effects of antiretrovirals on lymphocyte and sperm chromosomes and semen quality. Several antiretroviral regimens, all including a nucleoside component, were used. Lymphocyte metaphase analysis and sperm fluorescence in situ hybridization were used for cytogenetic studies. Semen analyses included conventional parameters (volume, concentration, viability, motility, and morphology). No significant effects on cytogenetic parameters, semen volume, or sperm concentration were detected. However, there were significant improvements in sperm motility for men with study entry CD4 cell counts >200 cells/mm(3), sperm morphology for men with entry CD4 cell counts < or =200 cells/mm(3), and the percentage of viable sperm in both groups. These findings suggest that nucleoside-containing antiretrovirals administered via recommended protocols do not induce chromosomal changes in lymphocytes or sperm but may produce improvements in semen quality.
Assuntos
Fármacos Anti-HIV/efeitos adversos , Quebra Cromossômica , Cromossomos/efeitos dos fármacos , Infecções por HIV/tratamento farmacológico , Infecções por HIV/imunologia , Linfócitos/efeitos dos fármacos , Metáfase/efeitos dos fármacos , Inibidores da Transcriptase Reversa/efeitos adversos , Espermatozoides/efeitos dos fármacos , Adulto , Aneuploidia , Fármacos Anti-HIV/uso terapêutico , Contagem de Linfócito CD4 , Diploide , Quimioterapia Combinada , Humanos , Hibridização in Situ Fluorescente , Estudos Longitudinais , Linfócitos/metabolismo , Linfócitos/patologia , Masculino , Pessoa de Meia-Idade , Inibidores da Transcriptase Reversa/uso terapêuticoRESUMO
Etoposide, a topoisomerase II inhibitor widely used in cancer therapy, is suspected of inducing secondary tumors and affecting the genetic constitution of germ cells. A better understanding of the potential heritable risk of etoposide is needed to provide sound genetic counseling to cancer patients treated with this drug in their reproductive years. We used a mouse model to investigate the effects of clinical doses of etoposide on the induction of chromosomal abnormalities in spermatocytes and their transmission to zygotes by using a combination of chromosome painting and 4',6-diamidino-2-phenylindole staining. High frequencies of chromosomal aberrations were detected in spermatocytes within 64 h after treatment when over 30% of the metaphases analyzed had structural aberrations (P < 0.01). Significant increases in the percentages of zygotic metaphases with structural aberrations were found only for matings that sampled treated pachytene (28-fold, P < 0.0001) and preleptotene spermatocytes (13-fold, P < 0.001). Etoposide induced mostly acentric fragments and deletions, types of aberrations expected to result in embryonic lethality, because they represent loss of genetic material. Chromosomal exchanges were rare. Etoposide treatment of pachytene cells induced aneuploidy in both spermatocytes (18-fold, P < 0.01) and zygotes (8-fold, P < 0.05). We know of no other report of an agent for which paternal exposure leads to an increased incidence of aneuploidy in the offspring. Thus, we found that therapeutic doses of etoposide affect primarily meiotic germ cells, producing unstable structural aberrations and aneuploidy, effects that are transmitted to the progeny. This finding suggests that individuals who undergo chemotherapy with etoposide may be at a higher risk for abnormal reproductive outcomes especially within the 2 months after chemotherapy.
Assuntos
Aberrações Cromossômicas , Etoposídeo/farmacologia , Metáfase/efeitos dos fármacos , Espermatócitos/efeitos dos fármacos , Aneuploidia , Animais , Antineoplásicos Fitogênicos/farmacologia , Cromossomos/efeitos dos fármacos , Cariotipagem , Masculino , Meiose/efeitos dos fármacos , Meiose/genética , Metáfase/genética , Camundongos , Espermatócitos/citologia , Translocação Genética/efeitos dos fármacosRESUMO
STUDY DESIGN: Data were collected from 27 patients who were participating in a rehabilitation program for chronic low back pain. The patients were tested on day 2 and day 11 of a 2-week rehabilitation program. OBJECTIVES: To determine specific characteristics of trunk motion associated with long-term dysfunction caused by low back pain of various origin, to determine if a neural network analysis system can be effective in distinguishing between patterns, and to determine if the rehabilitation has an effect on range and pattern of motion. SUMMARY OF BACKGROUND DATA: There is a lack of objective measures for evaluating the efficacy of rehabilitation programs. Numerous studies have established the difficulty of evaluating low back pain. Existing techniques, such as imaging methods, are in many cases either very rough and inaccurate or expensive and ineffective. A technique for evaluation of motion patterns in low back pain was developed based on analysis of dynamic motion features such as shape, velocity, and symmetry of movements. METHODS: Dynamic motion data were collected before and after rehabilitation from 27 patients with low back pain by using a triaxial goniometer. Range of motion and features of the movement, such as shape, velocity, and repetitiveness, were extracted for analysis. RESULTS: Motion features showed significant improvement after the rehabilitation program. CONCLUSIONS: A neural network based on kinematic data is an excellent model for classification of low back pain dysfunction. Such a system could markedly improve the management of low back pain for an individual patient.
Assuntos
Dor Lombar/fisiopatologia , Dor Lombar/reabilitação , Região Lombossacral/fisiopatologia , Movimento/fisiologia , Amplitude de Movimento Articular/fisiologia , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Redes Neurais de Computação , Recuperação de Função Fisiológica/fisiologia , Rotação , Resultado do TratamentoAssuntos
Anormalidades Congênitas/etiologia , Exposição Ambiental/efeitos adversos , Efeitos Tardios da Exposição Pré-Natal , Animais , Diretórios como Assunto , Feminino , Humanos , National Institutes of Health (U.S.) , Gravidez , Pesquisa , Estados Unidos , United States Environmental Protection AgencyRESUMO
Birth defects cause a myriad of societal problems and place tremendous anguish on the affected individual and his or her family. Current estimates categorize about 3% of all newborn infants as having some form of birth defect or congenital anomaly. As more precise means of detecting subtle anomalies become available this estimate, no doubt, will increase. Even though birth defects have been observed in newborns throughout history, our knowledge about the causes and mechanisms through which these defects are manifested is limited. For example, it has been estimated that around 20% of all birth defects are due to gene mutations, 5-10% to chromosomal abnormalities, and another 5-10% to exposure to a known teratogenic agent or maternal factor [D.A. Beckman, R.L. Brent, Mechanisms of teratogenesis. Ann. Rev. Pharmacol. Toxicol. 24 (1984) 483-500; K. Nelson, L.B. Holmes Malformations due to presumed spontaneous mutations in newborn infants, N. Engl. J. Med. 320 (1989) 19-23.]. Together, these percentages account for only 30-40%, leaving the etiology of more than half of all human birth defects unexplained. It has been speculated that environmental factors account for no more than one-tenth of all congenital anomalies [D.A. Beckman, R.L. Brent, Mechanisms of teratogenesis, Ann. Rev. Pharmacol. Toxicol. 24 (1984) 483-500]. Furthermore, since there is no evidence in humans that the exposure of an individual to any mutagen measurably increases the risk of congenital anomalies in his or her offspring' [J.F. Crow, C. Denniston, Mutation in human populations, Adv. Human Genet. 14 (1985) 59-121; J.M. Friedman, J.E. Polifka, Teratogenic Effects of Drugs: A Resource for Clinicians (TERIS). The John Hopkins University Press, Baltimore, 1994], the mutagenic activity of environmental agents and drugs as a factor in teratogenesis has been given very little attention. Epigenetic activity has also been given only limited consideration as a mechanism for teratogenesis. As new molecular methods are developed for assessing processes associated with teratogenesis, especially those with a genetic or an epigenetic basis, additional environmental factors may be identified. These are especially important because they are potentially preventable. This paper examines the relationships between chemicals identified as human teratogens (agents that cause birth defects) and their mutagenic activity as evaluated in one or more of the established short-term bioassays currently used to measure such damage. Those agents lacking mutagenic activity but with published evidence that they may otherwise alter the expressions or regulate interactions of the genetic material, i.e. exhibit epigenetic activity, have likewise been identified. The information used in making these comparisons comes from the published literature as well as from unpublished data of the U.S. National Toxicology Program (NTP).
Assuntos
Dano ao DNA , Teratogênicos/farmacologia , Animais , Anormalidades Congênitas/etiologia , DNA/efeitos dos fármacos , DNA/efeitos da radiação , Desenvolvimento Embrionário e Fetal/efeitos dos fármacos , Exposição Ambiental , Feminino , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Recém-Nascido , Infecções/complicações , Doenças Metabólicas , Camundongos , Testes de Mutagenicidade , Gravidez , Complicações na Gravidez/metabolismo , Complicações Infecciosas na Gravidez , Teratogênicos/toxicidadeRESUMO
STUDY DESIGN: Data were collected from 183 subjects who were randomly assigned to the training and test groups. During testing of the classification system, knowledge of the low back pain condition or motion characteristics of the patients in the test group was not made available to the system. OBJECTIVES: To determine specific characteristics of trunk motion associated with different categories of spinal disorders and to determine whether a neural network analysis system can be effective in distinguishing patterns. SUMMARY OF BACKGROUND DATA: Numerous studies have established the difficulty of evaluating lower back pain. Imaging techniques are expensive and ineffective in many cases. A technique for evaluation of lower back pain was developed on the basis of analysis of such dynamic motion features as shape, velocity, and symmetry of movements, using a neural network classification system. METHODS: Dynamic motion data were collected from 183 subjects using a triaxial goniometer. Features of the movement were extracted and provided as input to a two-stage neural network classifier governed by a radial basis function architecture. After training, the output of the classifier was compared with Québec Task Force pain classifications obtained for the patients. Linear and nonlinear classification techniques were compared. RESULTS: The system could determine low back pain classification from motion characteristics. The neural network classifier produced the best results with up to 85% accuracy on novel "validation" data. CONCLUSIONS: A neural network based on kinematic data is an excellent predictive model for classification of lower back pain. Such a system could markedly improve the management of lower back pain in the individual patient.
Assuntos
Dor Lombar/classificação , Dor Lombar/fisiopatologia , Movimento , Redes Neurais de Computação , Adulto , Feminino , Humanos , Cinese/classificação , Modelos Lineares , Dor Lombar/diagnóstico , Masculino , Dinâmica não Linear , Dor/diagnóstico , Dor/fisiopatologia , Amplitude de Movimento Articular , Doenças da Coluna Vertebral/diagnóstico , Doenças da Coluna Vertebral/fisiopatologiaRESUMO
Chemicals, by virtue of their varied interactions with biological molecules, are expected to differ in the way they may alter female reproduction. Reproductive toxicity may reflect effects either on the female germ cells or on various maternal processes such as ovulation, implantation, pregnancy, and parturition. In either case, the ultimate manifestation of chemical toxicity on female reproduction is a decrease in the number of normal young born. Very little information is available on the effects of chemicals that are nonhormonal in nature on the long-term ability of treated females to produce offspring. This report presents the results of long-term female total reproductive capacity (TRC) tests on 29 chemicals, including pharmaceuticals, pesticides, and alkylating and industrial agents. For each chemical, the minimum test involved an evaluation of the maximum tolerated dose administered as a single intraperitoneal injection. Females were single-pair mated with an untreated male for most of the female's reproductive life span (a minimum of 347 days posttreatment) and scored for the number of live births produced during this period. Confirmatory dominant lethal experiments or histological examinations for numbers of small follicles were carried out when mutagenic effects or cytotoxicity, respectively, were suspected as the basis for reduced fertility. Of the 29 chemicals studied, 17 had reproductive effects which may be grouped into one of three classes: (1) those that reduced the total number of young and litters per female, (2) those that reduced the total number of young but not of litters, and (3) those that had no significant effect on the total number of young produced but reduced the size of the first and/or second litters. The TRC provides a capacity for detecting a range of toxic insults upon female reproduction. Many of the chemicals were indeed shown to affect the reproductive performance of females through mutagenic and/or cytotoxic effects on follicles. In some cases, however, no causative mechanism could be identified for the observed reduction in reproductive performance. Nevertheless, with this report the number of chemicals tested by this TRC procedure has been quadrupled and the categories of chemicals tested have been substantially broadened.
Assuntos
Fertilidade/efeitos dos fármacos , Tamanho da Ninhada de Vivíparos/efeitos dos fármacos , Reprodução/efeitos dos fármacos , Xenobióticos/toxicidade , Alquilantes/toxicidade , Animais , Feminino , Injeções Intraperitoneais , Masculino , Camundongos , Testes de Mutagenicidade , Folículo Ovariano/efeitos dos fármacos , Folículo Ovariano/patologia , Ovário/efeitos dos fármacos , Ovário/patologia , Praguicidas/toxicidade , Gravidez , Coloração e Rotulagem , Relação Estrutura-Atividade , Xenobióticos/administração & dosagemRESUMO
Multi-color fluorescence in situ hybridization (FISH) was employed to investigate variations in the frequency of aneuploid spermatids produced by males derived from three separate lines of Robertsonian translocations in mice: Rb(2.8)2Lub, Rb(8.12)22Lub, and Rb(8.14)16Rma, each with one arm involving chromosome 8. The DNA probes used were specific for repetitive sequences on chromosomes 8 and X. Heterozygous males for these Robertsonian translocations produced approximately 1% of spermatids with hyperhaploid for chromosome 8. which was > 80 times higher than the frequency of sperm hyperhaploid for chromosome X within the same animals; consistent elevations in chromosome-8 sperm disomy were observed among lines. In addition, approximately 25% higher fractions of sperm aneuploidy were observed when the Robertsonian translocation was inherited from the father rather than from the mother (p = 0.009). These findings illustrate the sensitivity of the FISH procedure for detecting small differences in the hyperhaploidy in male germ cells and suggest that imprinted factors may influence sperm aneuploidy.
Assuntos
Aneuploidia , Hibridização in Situ Fluorescente/métodos , Espermátides/fisiologia , Translocação Genética/genética , Animais , Quimera , Feminino , Heterozigoto , Masculino , Camundongos , Cromossomo X/genéticaRESUMO
The evidence for mammalian germ cell mutagenicity induced by anticancer drugs is summarized. Primary attention is paid to the three major mouse germ cell mutagenicity tests- the dominant lethal, heritable translocation, and morphological specific locus tests- from which most germ cell mutagenicity data historically have been obtained. Of the 21 anticancer drugs reviewed, 16 have been tested in one or more of these three tests; with all 16 tested in the most common germ cell test, the male dominant lethal test, and 9 of the 16 also tested in the female dominant lethal test. The patterns of germ cell stage specificity for most of the anticancer drugs are similar, and generally resemble the patterns seen with other types of chemicals; however, some of the patterns are unique. For example, 2 of the 8 chemicals shown to induce dominant lethal mutations in female oocytes, do not induce dominant lethal mutations in male germ cells (adriamycin and platinol). Ten of the 16 chemicals tested in the dominant lethal test were positive in post-meiotic stages (spermatids through mature sperm), and seven also induced reciprocal translocations and/or specific locus mutations in post-meiotic stages. This propensity to induce mutations in post-meiotic stages has been observed with most mutagens. However, 5 of the anticancer drugs also induced dominant lethal mutations in spermatocytes (meiotic prophase cells) and one of them, 6-mercaptopurine, uniquely induced dominant lethal mutations exclusively in preleptotene spermatocytes. Finally, three of the anticancer drugs (melphalan, mitomycin C, procarbazine) are members of a very select group of chemicals shown to induce specific locus mutations in spermatogonial stem cells of mice. The implications for human risk are discussed.
Assuntos
Antineoplásicos/toxicidade , Mutagênicos/toxicidade , Animais , Feminino , Células Germinativas/efeitos dos fármacos , Humanos , Masculino , Camundongos , Testes de MutagenicidadeRESUMO
The chromosomal effects of chloral hydrate (CH) on germ cells of male mice were investigated using two methods to detect and characterize spermatid micronuclei (SMN); (a) anti-kinetochore immunofluorescence (SMN-CREST) and (b) multicolor fluorescence in situ hybridization with DNA probes for centromeric DNA and repetitive sequences on chromosome X (SMN-FISH). B6C3F1 mice received single intraperitoneal (i.p.) injections of 82.7, 165.4, or 413.5 mg/kg and round spermatids were sampled at three time intervals representing cells treated in late meiosis, early meiosis, or as spermatogonial stem cells. No increases in the frequencies of SMN were detected for cells treated during meiosis using either SMN-CREST or SMN-FISH methods. After spermatogonial stem-cell treatment, however, elevated frequencies of SMN were detected by both methods. With SMN-FISH, dose trends were observed both in the frequencies of spermatids containing micronuclei and in the frequency of spermatids carrying centromeric label. These findings corroborate the recent report by Allen and colleagues [Allen JW et al.(1994): Mutat. Res. 323:81-88] that CH treatment of spermatogenic stem cells induced SMN. Furthermore, our findings suggest that chromosomal malsegregation or loss may occur in spermatids long after CH treatment of stem cells. Further studies are needed to understand the mechanism of action of the CH effect on stem cells and to determine whether similar effects are induced in human males treated with CH.
Assuntos
Hidrato de Cloral/toxicidade , Testes para Micronúcleos , Espermátides/efeitos dos fármacos , Células-Tronco/efeitos dos fármacos , Anestésicos Intravenosos/toxicidade , Animais , Técnica Indireta de Fluorescência para Anticorpo/métodos , Hibridização in Situ Fluorescente/métodos , Cinetocoros/efeitos dos fármacos , Cinetocoros/imunologia , Masculino , Meiose , Camundongos , Camundongos Endogâmicos , Micronúcleos com Defeito Cromossômico/efeitos dos fármacos , Micronúcleos com Defeito Cromossômico/genéticaRESUMO
A 2 1/2-day workshop on germ cell aneuploidy was convened September 11-13, 1995 at the National Institute of Environmental Health Sciences in Research Triangle Park, North Carolina to discuss current understandings of the etiology and origin of human aneuploidy, especially in regard to potential environmental causes, and to identify gaps in our research knowledge. The workshop was designed to facilitate interactions among research experts conducting studies on the fundamental biology of chromosomal movement and segregation, on aneuploidy as a human clinical problem, and on toxicological aspects of aneuploidy induction. Overview presentations provided perspectives on aneuploidy as a human clinical problem, the genetics of aneuploidy, and the issues of concern in toxicological testing and regulatory risk assessment. The four chairs introduced the topics for each of their workgroups, setting the stage for subsequent, in-depth discussions on (1) chromosome mover components, (2) altered recombination, (3) parental age effects, and (4) differential chromosome susceptibility. From these discussions, gaps in our research knowledge related to the role of the environment in the etiology of aneuploidy and associated molecular, cellular, and genetic processes involved were identified, and will be used to establish a research agenda for filling those gaps.
Assuntos
Aneuploidia , Células Germinativas/fisiologia , Animais , Cromossomos Humanos , Síndrome de Down , Humanos , Idade Materna , Meiose , Camundongos , Mutagênicos/toxicidade , Recombinação GenéticaRESUMO
Cyclophosphamide (CP) is used to treat a wide range of neoplastic diseases as well as some non-malignant ones such as rheumatoid arthritis. It is also used as an immunosuppressive agent prior to organ transplantation. CP is, however, a known carcinogen in humans and produces secondary tumors. There is little absorption either orally or intravenously and 10% of the drug is excreted unchanged. CP is activated by hepatic mixed function oxidases and metabolites are delivered to neoplastic cells via the bloodstream. Phosphoramide mustard is thought to be the major anti-neoplastic metabolite of CP while acrolein, which is highly toxic and is produced in equimolar amounts, is thought to be responsible for most of the toxic side effects. DNA adducts have been formed after CP treatment in a variety of in vitro systems as well as in rats and mice using 3H-labeled CP. 32P-postlabeling techniques have also been used in mice. However, monitoring of adducts in humans has not yet been carried out. CP has also been shown to induce unscheduled DNA synthesis in a human cell line. CP has produced mutations in base-pair substituting strains of Salmonella tryphimurium in the presence of metabolic activation, but it has been shown to be negative in the E. coli chromotest. It has also been shown to be positive in Saccharomyces cerevisiae in D7 strain for many endpoints but negative in D62.M for aneuploidy/malsegregation. It has produced positive responses in Drosophila melanogaster for various endpoints and in Anopheles stephensi. In somatic cells, CP has been shown to produce gene mutations, chromosome aberrations, micronuclei and sister chromatid exchanges in a variety of cultured cells in the presence of metabolic activation as well as sister chromatid exchanges without metabolic activation. It has also produced chromosome damage and micronuclei in rats, mice and Chinese hamsters, and gene mutations in the mouse spot test and in the transgenic lacZ construct of Muta Mouse. Increases in chromosome damage and gene mutations have been found in the peripheral blood lymphocytes of nurses, pharmacists and female workers occupationally exposured to CP during its production or distribution. Chromosome aberrations, sister chromatid exchanges and gene mutations have been observed in somatic cells of patients treated therapeutically with CP. In general, there is a maximum dose and an optimum time for the detection of genetic effects because the toxicity associated with high doses of CP will affect cell division. In germ cells, CP has been shown to induce genetic damage in mice, rats and hamsters although the vast majority of such studies have used male mice.(ABSTRACT TRUNCATED AT 400 WORDS)
Assuntos
Ciclofosfamida/toxicidade , Mutação em Linhagem Germinativa , Testes de Mutagenicidade , Mutagênicos/toxicidade , Animais , Aberrações Cromossômicas , Adutos de DNA/análise , Dano ao DNA , Relação Dose-Resposta a Droga , Feminino , Humanos , Masculino , Camundongos , Testes de Mutagenicidade/métodos , Testes de Mutagenicidade/normas , Exposição Ocupacional/efeitos adversos , Ratos , Reprodutibilidade dos Testes , Medição de Risco , Troca de Cromátide Irmã , Especificidade da Espécie , Espermatozoides/efeitos dos fármacosRESUMO
The zygote and subsequent preimplantation stages of early mammalian development are susceptible to certain chemical perturbations that cause abnormal development of the conceptus. In certain cases, disruption in patterns of gene expression could be a primary event leading to abnormal development. To investigate this hypothesis, we treated pregnant mice with trans-retinoic acid, a known modulator of gene expression. Treatments were administered at various times during pregastrulation stages and the presumed onset of gastrulation. trans-Retinoic acid induced a distinctive set of malformations, as manifest by supernumerary and ectopic limbs and duplication of portions of the lower body, but only when administered during the period of 4.5-5.5 days after mating. (Other malformations were induced at different stages.) The limb and lower-body duplications suggest that exogenous trans-retinoic acid may influence not only the pattern for the hindlimbs but also that for the entire lower body. Since it appears likely that the embryos were affected in the late blastocyst and proamniotic-embryo stages, the provocative possibility arises that aspects of pattern formation of limbs and lower body actually occur prior to gastrulation.
Assuntos
Camundongos/embriologia , Teratogênicos , Tretinoína/farmacologia , Animais , Feminino , Idade Gestacional , Membro Posterior/anormalidades , Membro Posterior/embriologia , Masculino , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BLRESUMO
Phosphine (PH3) is a highly toxic grain fumigant to which there is significant human workplace exposure. To determine the in vivo cytogenetic effects of inhalation of PH3, male F344/N rats and B6C3F1 mice were exposed to target concentrations of 0, 1.25, 2.5, or 5 ppm PH3 for 6 hr/day for 9 days over an 11-day period. Approximately 20 hr after the termination of exposures, blood was removed from the mice and rats by cardiac puncture and the lymphocytes cultured for analyses of sister chromatid exchanges and chromosome aberrations in rats and mice, and micronuclei (MN) in cytochalasin B-induced binucleated lymphocytes from mice. In addition, bone marrow (rats) and peripheral blood (mice) smears were made for the analysis of MN in polychromatic and normochromatic erythrocytes. No significant increase in any of the cytogenetic endpoints was found at any of the concentrations examined. These results indicate that concentrations of PH3 up to 5 ppm are not genotoxic to rodents when administered by inhalation for 9 days during an 11-day period as measured by several cytogenetic assays. To evaluate the effects of PH3 on male germ cells, a dominant lethal test was conducted in male mice exposed to 5 ppm PH3 for 10 days over a 12-day period and mated to groups of untreated females (2 females/male) on each of 6 consecutive 4-day mating intervals. None of the 6 groups of females exhibited a significant increase in percent resorptions. These results indicate that exposure to 5 ppm PH3 by inhalation does not induce dominant lethality in male mouse germ cells at steps in spermatogenesis ranging from late differentiating spermatogonia/early primary spermatocytes through mature sperm.
Assuntos
Aberrações Cromossômicas/genética , Células Germinativas/efeitos dos fármacos , Inseticidas/toxicidade , Fosfinas/toxicidade , Troca de Cromátide Irmã/efeitos dos fármacos , Administração por Inalação , Animais , Medula Óssea/efeitos dos fármacos , Células da Medula Óssea , Citocalasina B/farmacologia , Eritrócitos/efeitos dos fármacos , Feminino , Humanos , Inseticidas/administração & dosagem , Linfócitos/efeitos dos fármacos , Masculino , Camundongos , Micronúcleos com Defeito Cromossômico/efeitos dos fármacos , Mutação/efeitos dos fármacos , Mutação/genética , Exposição Ocupacional , Fosfinas/administração & dosagem , Ratos , Ratos Endogâmicos F344 , Troca de Cromátide Irmã/genética , Espermatogênese/efeitos dos fármacosRESUMO
The toxicokinetics of salicylazosulfapyridine (SASP) and its metabolites were investigated in male and female B6C3F1 mice either following single intravenous (5 mg/kg) or oral (67.5, 675, 1350, and 2700 mg/kg) doses, or following three consecutive daily oral doses (675, 1350, and 2700 mg/kg). Plasma concentrations of SASP and its metabolites were quantified by HPLC. Upon intravenous administration, SASP rapidly disappeared from blood with a mean residence time of 0.45-0.78 hr. The only metabolite of SASP found in plasma after an intravenous dose was sulfapyridine (SP). In both sexes, the absolute oral bioavailability of SASP ranged between 16.6-18.2% at a dose of 67.5 mg/kg, and between 2.6-8.7% at doses of 675-2700 mg/kg. Following oral administration of SASP, both SP and AcSP were identified in plasma. The area under the plasma concentration-time curves (AUC) of SP at all four oral doses were approximately 21- to 32-fold or 5- to 25-fold greater than those of SASP in male or female mice, respectively. The acetylated form of SP and AcSP, produced AUC values higher than SASP but much less than SP. Multiple oral doses with SASP did not alter the temporal patterns of SASP absorption and elimination in comparison to a single dose. However, SP accumulated in both sexes following multiple oral doses. A gender-dependent difference in toxicokinetic profiles for SASP and SP was also observed. Female mice displayed a higher Cmax of SASP and SP than did male mice. Although the volume of distribution of SASP was similar in both sexes, the systemic clearance of SASP in males was about twice that observed in females.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Sulfassalazina/farmacocinética , Sulfassalazina/toxicidade , Administração Oral , Animais , Relação Dose-Resposta a Droga , Esquema de Medicação , Feminino , Injeções Intravenosas , Masculino , Camundongos , Camundongos Endogâmicos , Fatores Sexuais , Sulfassalazina/metabolismoRESUMO
Because genetically based diseases have a major impact on human health, the National Institute of Environmental Health Sciences (NIEHS) has conducted a research and testing program for more than a decade to address chemical induction of heritable genetic damage in the germ cells of mammals. Although most genetic disease results from preexisting mutations, a portion is due to the occurrence of new mutations. The supposition that exposure to mutagenic chemicals contributes to the occurrence of new mutations in the human population is strongly supported by the results from animal models. Such studies clearly demonstrate the potential of environmental chemicals to induce mutations in both somatic and reproductive cells of mammals. This NIEHS program has become a leader in the identification of genetic hazards in the environment and in the acquisition of animal model data used by regulatory agencies in assessing genetic risks to human health.
Assuntos
Poluentes Ambientais/efeitos adversos , Fertilidade/efeitos dos fármacos , Doenças Genéticas Inatas/induzido quimicamente , Células Germinativas/efeitos dos fármacos , Mutagênicos , Reprodução/efeitos dos fármacos , Animais , Previsões , Humanos , Mamíferos , CamundongosRESUMO
Limited comparative data in mice indicate that chemical mutagens that induce dominant lethal mutations in males are not necessarily effective in females, but those which are effective in females are generally equally or more effective in males. Recently, however, a few chemicals have been identified that are female-specific with respect to induction of dominant lethal mutations. The antitumor antibiotic adriamycin is among them. Another antitumor antibiotic, bleomycin was examined for its ability to induce dominant lethal mutations in the reproductive cells of male and female mice. No dominant lethal or cytotoxic effects were observed in males treated with bleomycin, even at a maximum tolerated dose. In females, on the other hand, a dose nearly 1/4 of that used in males induced not only a high level of dominant lethal mutations but also killed oocytes in certain stages of follicular development. The effectiveness of bleomycin in inducing dominant lethal mutations in mouse oocytes makes it a valuable tool for investigating whether gonadal transport, inherent differences in the configuration of chromatin in the germ cells of the two sexes or other factors are responsible for the differential susceptibility to bleomycin, which implies potential gender-specific genetic risk in cancer chemotherapy.
Assuntos
Bleomicina/toxicidade , Aberrações Cromossômicas , Mutação , Oócitos/efeitos dos fármacos , Animais , Feminino , Genes Dominantes/efeitos dos fármacos , Genes Letais/efeitos dos fármacos , Tamanho da Ninhada de Vivíparos/efeitos dos fármacos , Masculino , Camundongos , Testes de Mutagenicidade , Oócitos/fisiologia , Oogênese/efeitos dos fármacos , Espermatogênese/efeitos dos fármacos , Zigoto/efeitos dos fármacosRESUMO
The first randomized, blinded, placebo-controlled human trials of recombinant basic fibroblast growth factor (bFGF) for pressure sore treatment were performed. Three different concentrations of bFGF in five dosing schedules were tested for safety using hematology, serum chemistries, urinalysis, absorption, antibody formation, and signs of toxicity. Efficacy was evaluated by wound volumes, histology, and photography. No toxicity, significant serum absorption, or antibody formation occurred. In six of eight subgroups, there was a trend toward efficacy with bFGF treatment. When all subgroups were combined, comparison of the slopes of the regression curves of volume decrease over initial pressure sore volume demonstrated a greater healing effect for the bFGF-treated patients (p < 0.05). Histologically, bFGF-treated wound sections demonstrated increased fibroblasts and capillaries. More patients treated with bFGF achieved > 70% wound closure (p < 0.05). Blinded observers were able to distinguish differences in visual wound improvement between bFGF and placebo groups. These data suggest that bFGF may be effective in the treatment of chronic wounds.